Natera's Q2 Revenues Climb 26 Percent | GenomeWeb

This article has been updated with additional comments from Natera management.

NEW YORK (GenomeWeb) – Natera reported after the close of the market on Wednesday that its second quarter 2015 revenues climbed 26 percent over the second quarter 2014.

The San Carlos, California-based molecular diagnostic company reported total revenue of $45.1 million in Q2, up from $35.8 million in Q2 2014. It beat analysts' average estimate of $42.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.